The INSPIRE-Lung Study

Study summary

LungTalk and leveraging Facebook-targeted Advertisement (FBTA) addresses the call to develop and test multi-level, cancer communication interventions using innovative methods and designs. The study's long term goal is to increase lung cancer screening uptake among appropriate, high-risk individuals nationwide.

Ask AI to explain this study

Start here

Key things to know

Main goalScreening

This describes the study’s primary purpose.

What is being studiedLungTalk and Non-tailored intervention - Standard of practice

The study team can explain what participation involves.

Who it may be forLung Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Nov 21, 2025 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Hackensack Meridian Health

Study sponsor

Study overview

What this study is about

Purpose: Screening
Study type: Interventional
Phase: Not applicable
Sponsor: Hackensack Meridian Health
Interventions being studied: Behavioral: LungTalk; Behavioral: Non-tailored intervention - Standard of practice

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach

Supportive or behavioral care→

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

≥20-pack-year smoking history;
Individuals who currently smoke or quit smoking within the past 15 years

Reasons someone may not be able to joinExclusion criteria

Previously undergone LDCT for early detection of lung cancer, have a lung nodule or nodules that are currently being followed
Has ever been diagnosed with lung cancer
Individuals with impaired decision-making (because our primary outcome is decision-making, we will not include individuals with impaired decision-making)

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

Hackensack Meridian Health - Center for Discovery and InnovationNutley, New Jersey

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Nov 21, 2025. Always confirm current availability with the study team.

View original record ↗